Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study-Reference-Cited by-同舟云学术

Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study

Published:2016-12 Issue:4 Volume:1 Page:298-306
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Walter Fiona M,Mills Katie,Mendonça Silvia C,Abel Gary A,Basu Bristi,Carroll Nick,Ballard Sue,Lancaster John,Hamilton William,Rubin Greg P,Emery Jon D

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010;Parkin;Br J Cancer,2011

2. Pancreatic cancer;Vincent;Lancet,2011

3. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis;Weller;Br J Cancer,2012

4. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review;Neal;Br J Cancer,2015

5. Variation in promptness of presentation among 10 297 patients subsequently diagnosed with one of 18 cancers: Evidence from a national audit of cancer diagnosis in primary care;Keeble;Int J Cancer,2014

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection;PLOS Computational Biology;2024-08-29

2. Artificial Intelligence in Pancreatic Image Analysis: A Review;Sensors;2024-07-22

3. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments;Frontiers in Oncology;2024-07-01

4. The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma;Journal of Surgical Oncology;2024-06-18

5. Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma;Hong Kong Medical Journal;2024-04-09